Jeffrey Ojemann

Has grant

Professor

University of Washington
Country flagUnited States

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Recent Grants

Grant: Open

Motor Recovery through Plasticity-Inducing Cortical Stimulation

Open Date: 2022-04-01

Close Date: 2027-03-31

Grant: Close

US-German Research Proposal: Collaborative Research: Optimization of Human Cortical Stimulation

Open Date: 2015-09-01

Close Date: 2018-08-31

Grant: Close

Cortical GABA in pediatric sports concussion

Open Date: 2014-01-01

Close Date: 2015-12-31

Grant: Close

Neurosurgery research training in interdisciplinary neuroscience

Open Date: 2012-04-01

Close Date: 2017-06-30

Grant: Close

To design a self-contained, implantable ECoG array that can stimulate novel brain connections, which could lead to neuroprostheses to restore function lost to disease or injury.

Open Date: 2011-01-01

Close Date: 2012-12-31

Articles (4)

We report a novel developmental relationship between the human resting-state alpha rhythm frequency and the duration of intrinsic neural timescales. Using resting-state electrocorticography, we found that alpha frequency increased with age at either end of the sensorimotor-to-association cortical hierarchy, whereas intrinsic neural timescales only decreased with age in association regions. This negative correlation between alpha frequency and intrinsic timescale was only evident in association regions, further linking functional maturation and cortical hierarchy.

Year:

2026

The human neocortex underlies higher cognition and is the engine of complex thought. Yet our understanding of its neuronal diversity is limited by sparse access to tissue, inconsistent sampling across studies, and a lack of multiple modality data. Although single-cell transcriptomic taxonomies are an important framework for characterizing cell type diversity, transcriptomic information alone cannot reveal the cellular properties that define neuronal computations. To address this, we performed Patch-seq, a method for collecting Morphology, Electrophysiology, and Transcriptomic data from a single neuron. We focused on glutamatergic, neocortical, excitatory neurons, the principal long-range projecting neurons of the cortex, and systematically integrated their morphoelectric features with transcriptomic identity. In combination with spatial transcriptomic data, we interrogated 39 of 42 transcriptomically-defined neuron types with a layer-centric perspective. Morphoelectric properties, such as cortical depth, apical dendrite structure, and excitability clearly distinguish transcriptomic subclasses and support many finer transcriptomic types. Morphoelectric properties are influenced by spatial location in supragranular layers, while deeper layers exhibit greater heterogeneity. Cross-species comparisons reveal conserved subclass organization but pronounced differences in apical dendrite arborization between mouse and human, and surprising similarities between human and macaque. Together, these datasets provide a unified multimodal reference that advances our understanding of human cortical circuitry and establishes a foundation for experimental and computational studies of human brain function and disease.

Year:

2026

Objective Seizures that are refractory to medical and surgical therapy increase the risk of morbidity and mortality in children with epilepsy. Novel therapeutic trials for this population remain sparse and suboptimal. This Phase 1 study evaluates the (1) safety, tolerability, and (2) preliminary efficacy of ABI‐009 ( nab‐ rapamycin) in children with medically and surgically refractory epilepsy. Methods Children with medically intractable epilepsy and a history of resective surgery who experienced >8 seizures during the 30‐day baseline were included. Participants maintained their existing antiseizure medication regimens throughout the study. ABI‐009 was administered over 3 weeks using a 3 + 3 dose‐escalation design, with dosing cohorts of 5, 10, and 20 mg/m 2 . Treatment was then discontinued, and participants were observed for a 90‐day follow‐up period. Data were collected on seizure frequency, seizure type, adverse events, medical and laboratory assessments, the Quality of Life in Childhood Epilepsy (QOLCE), and the Nisonger Child Behavior Rating Form (NCBRF). Results Twelve participants received ABI‐009 and completed all study visits. Seizure etiologies included tuberous sclerosis complex, focal cortical dysplasia, and hemimegalencephaly, although Mammalian target of rapamycin involvement was not required for inclusion. No doses were missed, and dose escalation progressed through all levels. The maximum tolerated dose was 20 mg/m 2 . All 12 participants experienced at least one treatment‐emergent adverse event (TEAE), with the majority being mild (80%). No participants withdrew from the study voluntarily or by necessity secondary to TEAEs, and there were no serious adverse events. The median change in the weekly seizure rate was a 37.6% reduction from baseline to treatment completion. The treatment response rate (≥25% seizure reduction) was 66.7%, and two participants achieved seizure freedom by follow‐up. Significance ABI‐009 was deemed safe and tolerable in a pediatric cohort with medically and surgically refractory epilepsy, establishing a maximum tolerated dose of 20 mg/m 2 and showing early signs of efficacy.

Year:

2025

Maturation of human brain structure has been well-studied, but developmental changes to brain physiology are not as well understood. One consistent finding is that the peak alpha rhythm frequency (PAF) increases throughout childhood. Another is that resting-state functional connectivity shifts from sensorimotor regions in children to association regions in adolescents, a reorganization along a hierarchy called the sensorimotor-to-association (S-A) axis. In mature brains, the S-A axis has been parcellated physiologically using the duration of persistent neural activity, known as the intrinsic neural timescale (INT), which increases along the hierarchy. Here we studied the development of PAF and INT in a cohort of epilepsy patients 3 – 33 years of age undergoing intracranial electrocorticographic (ECoG) monitoring. Given the well-known developmental trajectory of PAF, and the ability to delineate hierarchy using INT, we hypothesized that changes to PAF and INT would correlate across development, but that their relationship may be influenced by hierarchy. Consequently, we predicted that age-dependent PAF increases would accompany INT decreases, and we tested whether their relationship varied between sensorimotor and association regions. We found that PAF increased significantly with age in both sensorimotor and association regions, while age-dependent INT decreases were only significant in association regions. Supporting this finding, we found a strong negative relationship between PAF and INT that was specific to association regions. Together, our results suggest that developmental divisions across the S-A axis manifest in the relationships between neurophysiological measures, providing further evidence that asynchronous development along the S-A axis depends on maturation of brain function. New & Noteworthy We report a novel developmental relationship between the human resting-state alpha rhythm frequency and the duration of intrinsic neural timescales. Using resting-state electrocorticography, we found that alpha frequency increased with age at either end of the sensorimotor-to-association cortical hierarchy, while intrinsic neural timescales only decreased with age in association regions. This negative correlation between alpha frequency and intrinsic timescale was only evident in association regions, further linking functional maturation and cortical hierarchy.

Year:

2025

Collaborators (22)

Rachel Dalley

Allen Institute for Brain Science

UNITED STATES
View details

Natalia Goriounova

University of Amsterdam

NETHERLANDS
View details

Christiaan de Kock

Assistent Professor

VU Amsterdam

NETHERLANDS
View details

Richard Ellenbogen

Professor and Chairman

University of Washington

UNITED STATES
View details

Anoop Patel

Associate Professor

Duke University

UNITED STATES
View details

Huib Mansvelder

University of Amsterdam

NETHERLANDS
View details

Eline Jasmijn Mertens

Assistant professor

Nyenrode Business University

NETHERLANDS
View details

Jason Scott Hauptman

Assistant Professor

University of Washington

UNITED STATES
View details

Hongkui Zeng

Executive Director

Allen Institute for Brain Science

UNITED STATES
View details

Sarah Walling-Bell

Allen Institute

UNITED STATES
View details

Andrew Ko

Assistant Professor

University of Washington

UNITED STATES
View details

Boudewijn Lelieveldt

Delft University of Technology

NETHERLANDS
View details

Gábor Tamás

European Research Council Advanced Scholar and Professor of Neuroscience

University of Szeged

HUNGARY
View details

Brian Kalmbach

Allen Institute for Brain Science

UNITED STATES
View details

Mark Wainwright

University of Washington

UNITED STATES
View details

Brian Long

Allen Institute for Brain Science

UNITED STATES
View details

Sara Jane Webb

Professor

Seattle Children's Research Institute

UNITED STATES
View details

Charles Cobbs

Swedish Neuroscience Institute

UNITED STATES
View details

Hannah Goldstein

Assistant Professor

Seattle Children's Hospital

UNITED STATES
View details

Manuel Ferreira

-

UNITED STATES
View details

Herman Tung

Allen Institute

UNITED STATES
View details

Samuel Emerson

Assistant Professor

University of Washington

UNITED STATES
View details